NASDAQ : ALPN

Alpine Immune Sciences, Inc.

$64.97 USD

$0.01 (0.02%)

Volume
4.29M
Average Volume
2.46M
Market Capitalization
$4.46B
P/E Ratio
-101.52
Dividend Yield
0.00%
Price Target
$55.00
Year High
$65.00
Year Low
$8.33
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$7.86
Company Overview

NASDAQ

Mitchell H. Gold

Biotechnology

Healthcare

ALPN

142

US

USD

https://www.alpineimmunesciences.com

206 788 4545

02083G100

0001626199

Liquidity Metrics

0.03

7.86

7.87

1.05

0.00

Sales & Valuation

$58.88M

75.70

9.91

-56.06

-1.59

Profitability

-$0.64

-$32.18M

-54.66%

-54.49%

-12.69%

-8.47%

P/E Metrics

-101.52

-1.28

-1.28

Analyst Price Target & Rating

$55.00

$65.00

$44.00

N/A

0/5

15 Analysts

18.13%

Poll Results

About Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Stock

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership wit ... h Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.

Frequently Asked Questions

What is the current Alpine Immune Sciences, Inc. (ALPN) stock price?

Alpine Immune Sciences, Inc.(NASDAQ:ALPN) stock price is $64.97 in the last trading session. During the trading session, ALPN stock reached the peak price of $65.0 while $8.33 was the lowest point it dropped to. The percentage change in ALPN stock occurred in the recent session was 0.02% while the dollar amount for the price change in ALPN stock was $0.01.

ALPN's industry and sector of operation?

The NASDAQ listed ALPN is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ALPN?

Paul Rickey | Senior Vice President, Chief Financial Officer, Treasurer & Secretary
Mitchell H. Gold | Executive Chairman & Chief Executive Officer
Stanford Peng | President and Head of Research & Development
Wolfgang Dummer | Chief Medical Officer
Andrew Seth Sandler | Chief Medical Officer

How many employees does ALPN have?

Number of ALPN employees currently stands at 142. ALPN operates from 188 East Blaine Street, Seattle, WA 98102, US.

Link for ALPN official website?

Official Website of ALPN is: https://www.alpineimmunesciences.com

How do I contact ALPN?

ALPN could be contacted at phone #206 788 4545 and can also be accessed through its website. ALPN operates from 188 East Blaine Street, Seattle, WA 98102, US.

How many shares of ALPN are traded daily?

The average number of ALPN shares traded daily for last 3 months was 2.46M.

What is the market cap of ALPN currently?

The market value of ALPN currently stands at $4.46B with its latest stock price at $64.97